PLA2G7

The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene.
Full Name
phospholipase A2 group VII
Function
Lipoprotein-associated calcium-independent phospholipase A2 involved in phospholipid catabolism during inflammatory and oxidative stress response (PubMed:7700381, PubMed:8624782, PubMed:2040620, PubMed:16371369, PubMed:17090529, PubMed:10066756).
At the lipid-aqueous interface, hydrolyzes the ester bond of fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity) (PubMed:2040620, PubMed:10504265).
Specifically targets phospholipids with a short-chain fatty acyl group at sn-2 position (PubMed:2040620).
Can hydrolyze phospholipids with long fatty acyl chains, only if they carry oxidized functional groups (PubMed:2040620, PubMed:8624782).
Hydrolyzes and inactivates platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine), a potent pro-inflammatory signaling lipid that acts through PTAFR on various innate immune cells (PubMed:10504265, PubMed:10066756, PubMed:7592717, PubMed:11590221, PubMed:7700381, PubMed:18434304, PubMed:16371369, PubMed:8675689, PubMed:8624782).
Hydrolyzes oxidatively truncated phospholipids carrying an aldehyde group at omega position, preventing their accumulation in low-density lipoprotein (LDL) particles and uncontrolled pro-inflammatory effects (PubMed:2040620, PubMed:7700381).
As part of high-density lipoprotein (HDL) particles, can hydrolyze phospholipids having long-chain fatty acyl hydroperoxides at sn-2 position and protect against potential accumulation of these oxylipins in the vascular wall (PubMed:17090529).
Catalyzes the release from membrane phospholipids of F2-isoprostanes, lipid biomarkers of cellular oxidative damage (PubMed:16371369).
Biological Process
Lipid oxidationManual Assertion Based On ExperimentIDA:BHF-UCL
Low-density lipoprotein particle remodelingManual Assertion Based On ExperimentIDA:BHF-UCL
Peptide hormone processingTAS:Reactome
Phosphatidylcholine catabolic processManual Assertion Based On ExperimentIDA:UniProtKB
Plasma lipoprotein particle oxidationManual Assertion Based On ExperimentIDA:BHF-UCL
Platelet activating factor catabolic processManual Assertion Based On ExperimentIDA:UniProtKB
Platelet activating factor metabolic processManual Assertion Based On ExperimentIDA:UniProtKB
Positive regulation of inflammatory responseManual Assertion Based On ExperimentTAS:BHF-UCL
Positive regulation of monocyte chemotaxisManual Assertion Based On ExperimentIDA:BHF-UCL
Cellular Location
Secreted, extracellular space
Associates with both LDL and HDL particles in plasma (PubMed:11590221, PubMed:12821559, PubMed:18434304, PubMed:10066756).
Mainly associates with pro-inflammatory electronegative LDL particles (PubMed:12821559).
Involvement in disease
Platelet-activating factor acetylhydrolase deficiency (PAFAD):
An enzymatic deficiency that results in exacerbated bodily response to inflammatory agents. It can be associated with several disease states including inflammatory gastrointestinal disorders, asthma and atopy. Asthmatic individuals with PAFAD may manifest aggravated respiratory symptoms.
Asthma (ASTHMA):
The most common chronic disease affecting children and young adults. It is a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions among many genes and between these genes and the environment. It is characterized by recurrent attacks of paroxysmal dyspnea, with wheezing due to spasmodic contraction of the bronchi.
Atopic hypersensitivity (ATOPY):
A condition characterized by predisposition to develop hypersensitivity reactions. Atopic individuals can develop eczema, allergic rhinitis and allergic asthma.
PTM
N-glycosylated. Macrophage-derived PLA2G7 carries sialylated complex-type N-glycans that hinder its binding to HDL particles.
View more

Anti-PLA2G7 antibodies

+ Filters
Loading...
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBT3134
Application*: WB
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBT4107
Application*: IH, IC
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: A921
Application*: IHC, WB
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBFYR0680
Application*: SE
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBFYR0679
Application*: SE
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human, Mouse
Clone: CB290A
Application*: ELISA, WB, IHC
Target: PLA2G7
Host: Mouse
Specificity: Human
Clone: IHC407
Application*: IH
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG3, κ
Specificity: Human
Clone: 5D1
Application*: SE, E
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human, Mouse
Clone: 2A1B6
Application*: E, WB, IH
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBYC-P416
Application*: WB, IC, P, C, E
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYCL-624
Application*: E, IH, WB
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBYJL-2307
Application*: E, WB
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG3, κ
Specificity: Human
Clone: CBYJL-2306
Application*: E
Target: PLA2G7
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYJL-2305
Application*: E, WB, P
More Infomation
Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized) Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
  • AActivation
  • AGAgonist
  • APApoptosis
  • BBlocking
  • BABioassay
  • BIBioimaging
  • CImmunohistochemistry-Frozen Sections
  • CIChromatin Immunoprecipitation
  • CTCytotoxicity
  • CSCostimulation
  • DDepletion
  • DBDot Blot
  • EELISA
  • ECELISA(Cap)
  • EDELISA(Det)
  • ESELISpot
  • EMElectron Microscopy
  • FFlow Cytometry
  • FNFunction Assay
  • GSGel Supershift
  • IInhibition
  • IAEnzyme Immunoassay
  • ICImmunocytochemistry
  • IDImmunodiffusion
  • IEImmunoelectrophoresis
  • IFImmunofluorescence
  • IGImmunochromatography
  • IHImmunohistochemistry
  • IMImmunomicroscopy
  • IOImmunoassay
  • IPImmunoprecipitation
  • ISIntracellular Staining for Flow Cytometry
  • LALuminex Assay
  • LFLateral Flow Immunoassay
  • MMicroarray
  • MCMass Cytometry/CyTOF
  • MDMeDIP
  • MSElectrophoretic Mobility Shift Assay
  • NNeutralization
  • PImmunohistologyp-Paraffin Sections
  • PAPeptide Array
  • PEPeptide ELISA
  • PLProximity Ligation Assay
  • RRadioimmunoassay
  • SStimulation
  • SESandwich ELISA
  • SHIn situ hybridization
  • TCTissue Culture
  • WBWestern Blot
online inquiry
Online Inquiry
Happy Holidays
Happy Holidays close ad